NASDAQ:CLXT - Calyxt Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$13.42 +0.69 (+5.42 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$13.42
Today's Range$12.77 - $13.55
52-Week Range$8.83 - $23.05
Volume39,745 shs
Average Volume53,269 shs
Market Capitalization$437.12 million
P/E Ratio-11.98
Dividend YieldN/A
Beta2.7
Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorConsumer Staples
Current SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$510,000.00
Book Value$2.08 per share

Profitability

Net Income$-25,980,000.00
Net Margins-6,256.67%

Miscellaneous

Employees35
Market Cap$437.12 million
OptionableNot Optionable

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) posted its quarterly earnings data on Wednesday, August, 1st. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.22) by $0.04. The firm earned $0.20 million during the quarter, compared to analysts' expectations of $0.10 million. Calyxt had a negative net margin of 6,256.67% and a negative return on equity of 33.08%. View Calyxt's Earnings History.

When is Calyxt's next earnings date?

Calyxt is scheduled to release their next quarterly earnings announcement on Tuesday, March 12th 2019. View Earnings Estimates for Calyxt.

What price target have analysts set for CLXT?

3 analysts have issued 12-month price targets for Calyxt's stock. Their predictions range from $13.00 to $27.00. On average, they expect Calyxt's share price to reach $19.3333 in the next twelve months. This suggests a possible upside of 44.1% from the stock's current price. View Analyst Price Targets for Calyxt.

What is the consensus analysts' recommendation for Calyxt?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Calyxt.

Has Calyxt been receiving favorable news coverage?

News stories about CLXT stock have trended neutral recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Calyxt earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 9.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days.

Who are some of Calyxt's key competitors?

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)
  • Mr. James A. Blome, Chief Exec. Officer
  • Mr. William Koschak, Chief Financial Officer (Age 49)
  • Mr. Eric Dutang, Principal Accounting Officer (Age 45)
  • Ms. Jennifer Moore, VP of Communications

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.19%), Mairs & Power INC (0.55%), Anchor Capital Advisors LLC (0.31%), Geode Capital Management LLC (0.28%), RMB Capital Management LLC (0.25%) and Millennium Management LLC (0.08%). Company insiders that own Calyxt stock include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, Manoj Sahoo, Michel Arbadji, Philippe Dumont and SA Cellectis. View Institutional Ownership Trends for Calyxt.

Which institutional investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Geode Capital Management LLC, Essex Investment Management Co. LLC and Essex Investment Management Co. LLC. Company insiders that have sold Calyxt company stock in the last year include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, Manoj Sahoo, Michel Arbadji and Philippe Dumont. View Insider Buying and Selling for Calyxt.

Which institutional investors are buying Calyxt stock?

CLXT stock was acquired by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC, RMB Capital Management LLC, Mairs & Power INC, Millennium Management LLC, Tibra Equities Europe Ltd, Paloma Partners Management Co, HRT Financial LLC and Bank of New York Mellon Corp. Company insiders that have bought Calyxt stock in the last two years include Philippe Dumont and SA Cellectis. View Insider Buying and Selling for Calyxt.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $13.42.

How big of a company is Calyxt?

Calyxt has a market capitalization of $437.12 million and generates $510,000.00 in revenue each year. The company earns $-25,980,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Calyxt employs 35 workers across the globe.

What is Calyxt's official website?

The official website for Calyxt is http://www.calyxt.com.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]


MarketBeat Community Rating for Calyxt (NASDAQ CLXT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  160 (Vote Outperform)
Underperform Votes:  168 (Vote Underperform)
Total Votes:  328
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel